Meta-analysis: Accuracy of quantitative ultrasound for identifying patients with osteoporosis

Annals of Internal Medicine

Volumn 144, Issue 11, 2006, Pages 832-841

  Nayak, Smita ^a   Olkin, Ingram ^a   Liu, Hau ^a   Grabe, Michael ^b   Gould, Michael K ^c   Allen, I Elaine ^d   Owens, Douglas K ^c   Bravata, Dena M ^a  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^d BABSON COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; CALCANEUS; CLINICAL TRIAL; DATA BASE; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; META ANALYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROBABILITY; QUANTITATIVE ANALYSIS; REVIEW; ROC CURVE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; ULTRASOUND; WORLD HEALTH ORGANIZATION; AGED; ARTICLE; ECHOGRAPHY; EPIDEMIOLOGY; FEMALE; HIP; MALE; MIDDLE AGED; RADIODENSITOMETRY; SPINE; STANDARD;

AGED; AGED, 80 AND OVER; BIAS (EPIDEMIOLOGY); CALCANEUS; DENSITOMETRY, X-RAY; FEMALE; HIP; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; SPINE;

EID: 33744977921     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-144-11-200606060-00009     Document Type: Review

References (99)

1. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993;94:646-50.
2. Lin JT, Lane JM. Osteoporosis: a review. Clin Orthop Relat Res. 2004:126-34.
3. National Osteoporosis Foundation. About Osteoporosis: Fast Facts. Vol. 2005. Washington, DC: National Osteoporosis Foundation; 2005.
4. Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA. 1999;282:1344-52.
5. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996;348:1535-41.
6. Liberman UA, Weiss SR, Bröll J, Minne HW, Quan H, Bell NH, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med. 1995;333:1437-43.
7. McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, et al. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med. 2001;344:333-40.
8. Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA. 1999;282:637-45.
9. Delmas PD, Ensrud KE, Adachi JD, Harper KD, Sarkar S, Gennari C, et al. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. J Clin Endocrinol Metab. 2002;87:3609-17.
10. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344:1434-41.
11. Stafford RS, Drieling RL, Hersh AL. National trends in osteoporosis visits and osteoporosis treatment, 1988-2003. Arch Intern Med. 2004;164:1525-30.
12. U.S. Preventive Services Task Force. Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med. 2002;137:526-8.
13. American College of Radiology. Expert Panel on Musculoskeletal Imaging. Osteoporosis and Bone Mineral Density. ACR Appropriateness Criteria. Reston, VA: American College of Radiology; 2001.
14. Faulkner KG. Update on bone density measurement. Rheum Dis Clin North Am. 2001;27:81-99.
15. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO study group. World Health Organ Tech Rep Ser. 1994;843:1-129.
16. Faulkner KG, Roberts LA, McClung MR. Discrepancies in normative data between Lunar and Hologic DXA systems. Osteoporos Int. 1996;6:432-6.
17. Genant HK, Grampp S, Glüer CC, Faulkner KG, Jergas M, Engelke K, et al. Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res. 1994;9:1503-14.
18. Lai KC, Goodsitt MM, Murano R, Chesnut CH 3rd. A comparison of two dual-energy x-ray absorptiometry systems for spinal bone mineral measurement. Calcif Tissue Int. 1992;50:203-8.
19. Pocock NA, Sambrook PN, Nguyen T, Kelly P, Freund J, Eisman JA. Assessment of spinal and femoral bone density by dual x-ray absorptiometry: comparison of lunar and hologic instruments. J Bone Miner Res. 1992;7:1081-4.
20. Prins SH, Jørgensen HL, Jørgensen LV, Hassager C. The role of quantitative ultrasound in the assessment of bone: a review. Clin Physiol. 1998;18:3-17.
21. Hans D, Fuerst T, Duboeuf F. Quantitative ultrasound bone measurement. Eur Radiol. 1997;7 Suppl 2:S43-50.
22. Danese RD, Licata AA. Ultrasound of the skeleton: review of its clinical applications and pitfalls. Curr Rheumatol Rep. 2001;3:245-8.
23. Stewart A, Reid DM. Precision of quantitative ultrasound: comparison of three commercial scanners. Bone. 2000;27:139-43.
24. Njeh CF, Hans D, Li J, Fan B, Fuerst T, He YQ, et al. Comparison of six calcaneal quantitative ultrasound devices: precision and hip fracture discrimination. Osteoporos Int. 2000;11:1051-62.
25. Bauer DC, Glüer CC, Cauley JA, Vogt TM, Ensrud KE, Genant HK, et al. Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. A prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med. 1997;157:629-34.
26. Hans D, Dargent-Molina P, Schott AM, Sebert JL, Cormier C, Kotzki PO, et al. Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet. 1996;348:511-4.
27. Pluijm SM, Graafmans WC, Bouter LM, Lips P. Ultrasound measurements for the prediction of osteoporotic fractures in elderly people. Osteoporos Int. 1999;9:550-6.
28. Khaw KT, Reeve J, Luben R, Bingham S, Welch A, Wareham N, et al. Prediction of total and hip fracture risk in men and women by quantitative ultrasound of the calcaneus: EPIC-Norfolk prospective population study. Lancet. 2004;363:197-202.
29. Wüster C, Heilmann P, Pereira-Lima J, Schlegel J, Anstätt K, Soballa T. Quantitative ultrasonometry (QUS) for the evaluation of osteoporosis risk: reference data for various measurement sites, limitations and application possibilities. Exp Clin Endocrinol Diabetes. 1998;106:277-88.
30. Brunader R, Shelton DK. Radiologic bone assessment in the evaluation of osteoporosis. Am Fam Physician. 2002;65:1357-64.
31. Jørgensen HL, Warming L, Bjarnason NH, Andersen PB, Hassager C. How does quantitative ultrasound compare to dual x-ray absorptiometry at various skeletal sites in relation to the WHO diagnosis categories? Clin Physiol. 2001;21:51-9.
32. Marín F, López-Bastida J, Díez-Pérez A, Sacristán JA. Bone mineral density referral for dual-energy X-ray absorptiometry using quantitative ultrasound as a prescreening tool in postmenopausal women from the general population: a cost-effectiveness analysis. Calcif Tissue Int. 2004;74:277-83.
33. Genant HK, Engelke K, Fuerst T, Glüer CC, Grampp S, Harris ST, et al. Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res. 1996;11:707-30.
34. Njeh CF, Boivin CM, Langton CM. The role of ultrasound in the assessment of osteoporosis: a review. Osteoporos Int. 1997;7:7-22.
35. Gregg EW, Kriska AM, Salamone LM, Roberts MM, Anderson SJ, Ferrell RE, et al. The epidemiology of quantitative ultrasound: a review of the relationships with bone mass, osteoporosis and fracture risk. Osteoporos Int. 1997;7:89-99.
36. Kanis JA, Glüer CC. An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation. Osteoporos Int. 2000;11:192-202.
37. Frost ML, Blake GM, Fogelman I. Can the WHO criteria for diagnosing osteoporosis be applied to calcaneal quantitative ultrasound? Osteoporos Int. 2000;11:321-30.
38. Damilakis J, Perisinakis K, Gourtsoyiannis N. Imaging ultrasonometry of the calcaneus: optimum T-score thresholds for the identification of osteoporotic subjects. Calcif Tissue Int. 2001;68:219-24.
39. Osteoporosis prevention, diagnosis, and therapy. NIH Consen Statement. 2000;17:1-45.
40. Ultrasonography of peripheral sites for selecting patients for pharmacologic treatment for osteoporosis. TEC Bull (Online). 2002;19:25-8.
41. Truscott JG, Simpson M, Stewart SP, Milner R, Westmacott CF, Oldroyd B, et al. Bone ultrasonic attenuation in women: reproducibility, normal variation and comparison with photon absorptiometry. Clin Phys Physiol Meas. 1992;13:29-36.
42. Young H, Howey S, Purdie DW. Broadband ultrasound attenuation compared with dual-energy x-ray absorptiometry in screening for postmenopausal low bone density. Osteoporos Int. 1993;3:160-4.
43. Massie A, Reid DM, Porter RW. Screening for osteoporosis: comparison between dual energy x-ray absorptiometry and broadband ultrasound attenuation in 1000 perimenopausal women. Osteoporos Int. 1993;3:107-10.
44. Salamone LM, Krall EA, Harris S, Dawson-Hughes B. Comparison of broadband ultrasound attenuation to single x-ray absorptiometry measurements at the calcaneus in postmenopausal women. Calcif Tissue Int. 1994;54:87-90.
45. van Daele PL, Burger H, Algra D, Hofman A, Grobbee DE, Birkenhäger JC, et al. Age-associated changes in ultrasound measurements of the calcaneus in men and women: the Rotterdam Study. J Bone Miner Res. 1994;9:1751-7.
46. Turner CH, Peacock M, Timmerman L, Neal JM, Johnson CC Jr. Calcaneal ultrasonic measurements discriminate hip fracture independently of bone mass. Osteoporos Int. 1995;5:130-5.
47. Ross P, Huang C, Davis J, Imose K, Yates J, Vogel J, et al. Predicting vertebral deformity using bone densitometry at various skeletal sites and calcaneus ultrasound. Bone. 1995;16:325-32.
48. Roux C, Fournier B, Laugier P, Chappard C, Kolta S, Dougados M, et al. Broadband ultrasound attenuation imaging: a new imaging method in osteoporosis. J Bone Miner Res. 1996;11:1112-8.
49. El-Desouki MI, Sherafzal MS, Othman SA. Comparison of bone mineral density with dual energy x-ray absorptiometry, quantitative ultrasound and single energy x-ray absorptiometry. Saudi Med J. 2005;26:1346-50.
50. Pocock NA, Culton NL, Gilbert GR, Hoy ML, Babicheva R, Chu JM, et al. Potential roles for quantitative ultrasound in the management of osteoporosis. Med J Aust. 2000;173:355-8.
51. Greenspan SL, Cheng S, Miller PD, Orwoll ES. Clinical performance of a highly portable, scanning calcaneal ultrasonometer. Osteoporos Int. 2001;12:391-8.
52. Langton CM, Ballard PA, Langton DK, Purdie DW. Maximising the cost effectiveness of BMD referral for DXA using ultrasound as a selective population pre-screen. Technol Health Care. 1997;5:235-41.
53. Langton CM, Langton DK, Beardsworth SA. Comparison of accuracy and cost effectiveness of clinical criteria and BUA for referral for BMD assessment by DXA in osteoporotic and osteopenic perimenopausal subjects. Technol Health Care. 1999;7:319-30.
54. Boonen S, Nijs J, Borghs H, Peeters H, Vanderschueren D, Luyten FP. Identifying postmenopausal women with osteoporosis by calcaneal ultrasound, metacarpal digital x-ray radiogrammetry and phalangeal radiographic absorptiometry: a comparative study. Osteoporos Int. 2005;16:93-100.
55. Lippuner K, Fuchs G, Ruetsche AG, Perrelet R, Casez JP, Neto I. How well do radiographic absorptiometry and quantitative ultrasound predict osteoporosis at spine or hip? A cost-effectiveness analysis. J Clin Densitom. 2000;3:241-9.
56. Nairus J, Ahmadi S, Baker S, Baran D. Quantitative ultrasound: an indicator of osteoporosis in perimenopausal women. J Clin Densitom. 2000;3:141-7.
57. Díez-Pérez A, Marín F, Vila J, Abizanda M, Cervera A, Carbonell C, et al. Evaluation of calcaneal quantitative ultrasound in a primary care setting as a screening tool for osteoporosis in postmenopausal women. J Clin Densitom. 2003;6:237-45.
58. Goemaere S, Zmierczak H, Van Pottelbergh I, Kaufman JM. Ability of peripheral bone assessments to predict areal bone mineral density at hip in community-dwelling elderly men. J Clin Densitom. 2002;5:219-28.
59. Sørensen HA, Jørgensen NR, Jensen JE, Rasmussen AM, Hansen B, Nielsen SP, et al. Comparison of quantitative ultrasound and dual x-ray absorptiometry in estrogen-treated early postmenopausal women. J Clin Densitom. 2001;4:97-104.
60. Glüer CC, Hans D. How to use ultrasound for risk assessment: a need for defining strategies [Editorial]. Osteoporos Int. 1999;9:193-5.
61. Kraemer DF, Nelson HD, Bauer DC, Helfand M. Economic comparison of diagnostic approaches for evaluating osteoporosis in older women. Osteoporos Int. 2006; 68-76. Epub 2005 12 May.
62. Hamdy RC, Petak SM, Lenchik L. Which central dual x-ray absorptiometry skeletal sites and regions of interest should be used to determine the diagnosis of osteoporosis? J Clin Densitom. 2002;5 Suppl:S11-8.
63. Leib ES, Lewiecki EM, Binkley N, Hamdy RC. Official positions of the International Society for Clinical Densitometry. J Clin Densitom. 2004;7:1-6.
64. Deng HW, Li JL, Li J, Davies KM, Recker RR. Heterogeneity of bone mineral density across skeletal sites and its clinical implications. J Clin Densitom. 1998;1:339-53.
65. Meunier PJ, Delmas PD, Eastell R, McClung MR, Papapoulos S, Rizzoli R, et al. Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines. Clin Ther. 1999;21:1025-44.
66. Hodgson SF, Watts NB, Bilezikian JP, Clarke BL, Gray TK, Harris DW, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract. 2003;9:544-64.
67. Brown JP, Josse RG. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ. 2002;167:S1-34.
68. Hedges LV, Olkin I. Statistical Methods for Meta-analysis. San Diego, CA: Academic Pr; 1985.
69. Cooper H, Hedges LV. The Handbook of Research Synthesis. New York: Russell Sage Foundation; 1994.
70. Working H, Hotelling H. Applications of the theory of error to the interpretation of trends. J Am Stat Assoc. 1929;24:73-85.
71. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med. 1993;12:1293-316.
72. Littenberg B, Moses LE. Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method. Med Decis Making. 1993;13:313-21.
73. Sox HC, Blatt MA, Higgins MC, Marton KI. Medical Decision Making. Woburn, MA: Butterworth-Heinemann; 1988.
74. Adler RA, Funkhouser HL, Holt CM. Utility of heel ultrasound bone density in men. J Clin Densitom. 2001;4:225-30.
75. Ayers M, Prince M, Ahmadi S, Baran DT. Reconciling quantitative ultrasound of the calcaneus with x-ray-based measurements of the central skeleton. J Bone Miner Res. 2000;15:1850-5.
76. Bachman DM, Crewson PE, Lewis RS. Comparison of heel ultrasound and finger DXA to central DXA in the detection of osteoporosis. Implications for patient management. J Clin Densitom. 2002;5:131-41.
77. Cetin A, Ertürk H, Celiker R, Sivri A, Hascelik Z. The role of quantitative ultrasound in predicting osteoporosis defined by dual x-ray absorptiometry. Rheumatol Int. 2001;20:55-9.
78. Dubois EF, van den Bergh JP, Smals AG, van de Meerendonk CW, Zwinderman AH, Schweitzer DH. Comparison of quantitative ultrasound parameters with dual energy x-ray absorptiometry in pre- and postmenopausal women. Neth J Med. 2001;58:62-70.
79. Falgarone G, Porcher R, Duché A, Kolta S, Dougados M, Roux C. Discrimination of osteoporotic patients with quantitative ultrasound using imaging or non-imaging device. Joint Bone Spine. 2004;71:419-23.
80. Hodson J, Marsh J. Quantitative ultrasound and risk factor enquiry as predictors of postmenopausal osteoporosis: comparative study in primary care. BMJ. 2003;326:1250-1.
81. Ikeda Y, Iki M, Morita A, Aihara H, Kagamimori S, Kagawa Y, et al. Age-specific values and cutoff levels for the diagnosis of osteoporosis in quantitative ultrasound measurements at the calcaneus with SAHARA in healthy Japanese women: Japanese population-based osteoporosis (JPOS) study. Calcif Tissue Int. 2002;71:1-9.
82. Kung AW, Ho AY, Sedrine WB, Reginster JY, Ross PD. Comparison of a simple clinical risk index and quantitative bone ultrasound for identifying women at increased risk of osteoporosis. Osteoporos Int. 2003;14:716-21.
83. Langton CM, Langton DK. Comparison of bone mineral density and quantitative ultrasound of the calcaneus: site-matched correlation and discrimination of axial BMD status. Br J Radiol. 2000;73:31-5.
84. López-Rodríguez F, Mezquita-Raya P, de Dios Luna J, Escobar-Jiménez F, Muñoz-Torres M. Performance of quantitative ultrasound in the discrimination of prevalent osteoporotic fractures in a bone metabolic unit. Bone. 2003;32:571-8.
85. Naganathan V, March L, Hunter D, Pocock NA, Markovey J, Sambrook PN. Quantitative heel ultrasound as a predictor for osteoporosis. Med J Aust. 1999;171:297-300.
86. Pearson D, Masud T, Sahota O, Earnshaw S, Hosking D. A comparison of calcaneal dual-energy x-ray absorptiometry and calcaneal ultrasound for predicting the diagnosis of osteoporosis from hip and spine bone densitometry. J Clin Densitom. 2003;6:345-52.
87. Sim MF, Stone M, Johansen A, Evans W. Cost effectiveness analysis of BMD referral for DXA using ultrasound as a selective pre-screen in a group of women with low trauma Colles' fractures. Technol Health Care. 2000;8:277-84.
88. Varney LF, Parker RA, Vincelette A, Greenspan SL. Classification of osteoporosis and osteopenia in postmenopausal women is dependent on site-specific analysis. J Clin Densitom. 1999;2:275-83.
89. Kung AW, Ho AY, Ross PD, Reginster JY. Development of a clinical assessment tool in identifying Asian men with low bone mineral density and comparison of its usefulness to quantitative bone ultrasound. Osteoporos Int. 2005;16:849-55.
90. Sim MF, Stone MD, Phillips CJ, Cheung WY, Johansen A, Vasishta S, et al. Cost effectiveness analysis of using quantitative ultrasound as a selective prescreen for bone densitometry. Technol Health Care. 2005;13:75-85.
91. Cook RB, Collins D, Tucker J, Zioupos P. Comparison of questionnaire and quantitative ultrasound techniques as screening tools for DXA. Osteoporos Int. 2005;16:1565-75.
92. Cook RB, Collins D, Tucker J, Zioupos P. The ability of peripheral quantitative ultrasound to identify patients with low bone mineral density in the hip or spine. Ultrasound Med Biol. 2005;31:625-32.
93. Alenfeld FE, Engelke K, Schmidt D, Brezger M, Diessel E, Felsenberg D. Diagnostic agreement of two calcaneal ultrasound devices: the Sahara bone sonometer and the Achilles. Br J Radiol. 2002;75:895-902.
94. Grampp S, Genant HK, Mathur A, Lang P, Jergas M, Takada M, et al. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification. J Bone Miner Res. 1997;12:697-711.
95. Zochling J, Nguyen TV, March LM, Sambrook PN. Quantitative ultrasound measurements of bone: measurement error, discordance, and their effects on longitudinal studies. Osteoporos Int. 2004;15:619-24.
96. Melton LJ 3rd. How many women have osteoporosis now? J Bone Miner Res. 1995;10:175-7.
97. Hans D, Hartl F, Krieg MA. Device-specific weighted T-score for two quantitative ultrasounds: operational propositions for the management of osteoporosis for 65 years and older women in Switzerland. Osteoporos Int. 2003;14:251-8.
98. The Clinical Use of Ultrasound. Bedford, MA: Hologic; 2003.
99. Stone KL, Seeley DG, Lui LY, Cauley JA, Ensrud K, Browner WS, et al. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res. 2003;18:1947-54.